Oruka Therapeutics (ORKA) Q1 2025 Earnings

6MarConfirmed
Q3 2024
Q4 2024
Q1 2025
-1.46
-1.11
-0.75
-0.4

Details

Expected EPS
-0.681814
Actual EPS
-0.49
Surprise EPS
0.19
Surprise Percent
+28.13%

Description

Oruka Therapeutics (ORKA) has reported earnings of -0.49 per share for Q1 2025.

0 Comments

Share your thoughts